Expression of pRb and PD-L1 as potential predictive biomarkers for oncolytic adenovirus based gene therapy of urothelial carcinoma

被引:0
|
作者
Lau, Ryan [1 ]
Chin, Curtis [2 ]
Yu, Weibo [1 ]
Grandi, Paola [3 ]
Shen, Shihpei [3 ]
Lai, Calvin [4 ]
Rao, Jianyu
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Cold Genesys, Santa Ana, CA USA
[4] Cold Genesys, Costa Mesa, CA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
888
引用
收藏
页数:2
相关论文
共 50 条
  • [11] CT-based radiomics for prediction of PD-L1 expression in urothelial carcinoma
    Ku, J. Y.
    Seo, Y. J.
    Kim, K. H.
    Kim, S. D.
    Hwang, E. C.
    Ha, H. K.
    EUROPEAN UROLOGY, 2023, 83 : S849 - S850
  • [12] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [13] PD-L1 and IDO Expression in Upper Tract Urothelial Carcinoma
    Cathro, Helen
    Ju, Jennifer
    Davick, Jonathan
    Gru, Alejandro A.
    Culp, Stephen
    MODERN PATHOLOGY, 2019, 32
  • [14] PD-L1 and IDO Expression in Upper Tract Urothelial Carcinoma
    Cathro, Helen
    Ju, Jennifer
    Davick, Jonathan
    Gru, Alejandro A.
    Culp, Stephen
    LABORATORY INVESTIGATION, 2019, 99
  • [15] Anti-PD-1/PD-L1 therapy for renal cell carcinoma: challenges in the development of predictive biomarkers
    Kato, Renpei
    Obara, Wataru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (07) : 667 - 669
  • [16] Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Thou, Hui
    Lu, Hongyan
    Tang, Kun
    Ye, Zhangqun
    DISEASE MARKERS, 2020, 2020
  • [17] PREDICTIVE AND PROGNOSTIC ROLE OF PD-L1 IN UROTHELIAL CARCINOMA PATIENTS WITH ANTI-PD-1/PD-L1 THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tang, Kun
    Jiang, Kehua
    Zhou, Hui
    Liu, Haoran
    Ye, Zhangqun
    Xu, Hua
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1040 - E1040
  • [18] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [19] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [20] Urothelial Carcinoma with Sarcomatoid Transformation: An Analysis of PD-L1 Expression Status
    Gupta, Sounak
    Dashti, Nooshin K.
    Thapa, Prabin
    Hernandez, Loren Herrera
    Raghunathan, Aditya
    Sukov, William
    Jimenez, Rafael
    Boorjian, Stephen
    Frank, Igor
    Cheville, John
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 891 - 891